Dr Loh Ne-Ron

Dr Loh is a Senior Consultant Paediatric Neurologist at KKH, bringing diverse medical expertise spanning 30 years in international clinical practice, research, and medico-legal consultation. After qualifying in medicine in Ireland and obtaining a master's degree in infectious disease from the London School of Hygiene and Tropical Medicine, he completed fellowship training in endocrinology, higher specialist training in Bristol, and a neurology fellowship in Brisbane, Australia.

His current practice encompasses the full spectrum of general paediatric neurological conditions, with specialist expertise in Tuberous Sclerosis Complex (TSC) and difficult-to-treat headache disorders. He has established a comprehensive TSC clinic at KKH offering coordinated care where patients access treatment for multiorgan issues in a single consultation. This builds upon his eight years heading the largest Tuberous Sclerosis Centre in the UK. He remains active in collaborative TSC research.

Dr Loh provides advanced neuromodulation treatments for headaches and expert assessment for dizziness disorders in children. His work is supported by his role as investigator for numerous migraine and epilepsy trials and his lecturing at Royal Society of Medicine and Royal College of Paediatrics events.

During his UK career, Dr Loh developed medico-legal expertise in safeguarding assessments and diagnostic review cases, including expert witness testimony, providing insights into clinical decision-making and patient safety. He also served as a GMC consultant appraiser.

• Neurology Fellowship – Australia 2009
• Endocrinology Fellowship – UK 2003
• MSc, DTM&H – UK 2001
• MRCPCH – UK 2000
• DCH – Ireland 1997
  
• MB BCh BAO – Ireland 1995

• International Child Neurology Association member
• Royal College of Paediatrics and Child Health member
• British Paediatric Neurology Association member
• Royal College press panel and consultant appointment committee member
• GMC consultant appraiser

• Erenumab in Paediatric Migraine – Principal Investigator 2019-2023
• International Collaboration Infantile Spasm Study – Principal Investigator 2010-2015

• Dixon R, O’Callaghan F, Loh NR,. Renal Lipomorphosis in Tuberous Sclerosis patients. Abstract in TSC Research Conference, Sept 2023. Washington DC.
• Smith CJ, Smith ZG, Rasool H, Cullen K, Ghosh M, Woolley TE, Uzun O, Loh NR, Tucker D, Syed YA. Unravelling the Clinical Co-Morbidity and Risk Factors Associated with Agenesis of the Corpus Callosum. J Clin Med. 2023 May 23;12(11):3623
• Loh NR, Whitehouse WP, Howells R. What is new in migraine management in children and young people? Arch Dis Child. 2022 Dec;107(12):1067-1072
• Robinson J, Uzun O, Loh NR et al. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort. BMC Med. 2022 Apr 20;20(1):123
• Loh NR. Greater Occipital Nerve block in paediatric headaches. Cephalalgia. 2019;39(1_suppl):1-337. 
• O'Callaghan FJK, et al. International Collaborative Infantile Spasms Study (ICISS) investigators. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Health. 2018 Oct;2(10):715-725.
• Yeap, ML, Loh NR, Babiker MO. Abstract- Clinical Utility for gene panel testing in childhood epilepsy. European Journal of Paediatric Neurology 2017 Volume 21, Supplement 1, Pages e1-e254
• Sutchfield C, Loh NR. Focal epilepsy presenting as a bath-induced paroxysmal event/breath-holding attack. Epilepsy & Behavior Case Reports 2 (2014) 102–104
• Loh NR, Malone S. Treatment of twin neonatal reflex anoxic seizure with Piracetam. Abstract in Developmental Medicine & Child Neurology. (2012)Vol 54, Iss s4/p5-212.
• Loh NR, Malone S. Febrile encephalopathy in Queensland 2004-8. Abstract in Developmental Medicine & Child Neurology. (2012) Vol 54, Iss s4/p5-212.
• Loh NR, Appleton DB. Untreated recurrent acute necrotising encephalopathy associated with RANBP2 mutation, and normal outcome in a Caucasian boy. Eur J Ped 2010, 169 (10) 1299-1302.
• Loh NR, Mahmoud M. Duchenne Muscular Dystrophy transition in the Southwest. Abstract Neuromuscular Disorders Oct 2008, 18(9-10):724-833.
• Loh NR, Jadresic LJ, Whitelaw A. Neonatal Encephalopathy: Incontinentia pigmenti. Acta Paediatrica 2008,97(3):379-81
• Loh N, Porter W, Webb M. The “obvious” non-accidental injury. Irish Med J 2005 Jul-Aug;98(7):217-8.
• Loh N, Behren R. Epidemiology of imported disease in the UK. Abstract in 10th International congress on Infectious Diseases, Singapore 11th March 2002.
• Loh NR, Kalamanathan M, Loftus BG. Retrospective study of 10 Years (1986-95) of Paediatric Asthma admissions in University College Hospital Galway. Irish Med J. 1998 Dec; 91(6): 215.
• Loh NR, Kelleher CC, Long S, Loftus BG" Can a 3-minute intervention increase breast-feeding rates?" Irish Med J.1997 Apr-May; 90(3):100-1